HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jiang Cao Selected Research

Antisense Elements (Genetics)

1/2022Radiosynthesis of a novel antisense imaging probe targeting LncRNA HOTAIR in malignant glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jiang Cao Research Topics

Disease

47Neoplasms (Cancer)
03/2022 - 07/2002
15Leukemia
01/2022 - 10/2003
14Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 06/2013
12Breast Neoplasms (Breast Cancer)
08/2017 - 05/2004
11Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
03/2019 - 01/2011
11Stomach Neoplasms (Stomach Cancer)
01/2019 - 10/2005
10Multiple Myeloma
10/2022 - 10/2019
9Carcinoma (Carcinomatosis)
01/2022 - 01/2002
9Infections
01/2021 - 06/2012
9Graft vs Host Disease (Graft-Versus-Host Disease)
01/2021 - 11/2007
9Colorectal Neoplasms (Colorectal Cancer)
05/2016 - 07/2002
6Carcinogenesis
10/2017 - 01/2008
5Cytokine Release Syndrome
01/2022 - 01/2020
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2019 - 11/2016
4Hepatocellular Carcinoma (Hepatoma)
01/2019 - 03/2015
4Neoplasm Metastasis (Metastasis)
01/2017 - 07/2002
3Aplastic Anemia (Anemia, Hypoplastic)
12/2022 - 06/2017
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2022 - 11/2019
3Atrial Fibrillation
01/2022 - 11/2005
3Inflammation (Inflammations)
05/2021 - 01/2012
3Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 01/2020
3Hypoxia (Hypoxemia)
06/2019 - 09/2006
3Lymphatic Metastasis
02/2010 - 10/2005
2Compression Fractures (Compression Fracture)
05/2022 - 01/2021
2Ventricular Premature Complexes (Premature Ventricular Contraction)
01/2022 - 11/2015
2Fibrosis (Cirrhosis)
03/2021 - 01/2021
2B-Cell Leukemia (Leukemia, B Cell)
01/2021 - 10/2019
2Lymphoma (Lymphomas)
01/2021 - 02/2010
2Heart Failure
01/2021 - 01/2016
2Melanoma (Melanoma, Malignant)
02/2020 - 04/2006
2Adenocarcinoma
01/2020 - 08/2010
2Philadelphia Chromosome
12/2014 - 06/2013
2Hypertension (High Blood Pressure)
12/2010 - 10/2009
2Liver Neoplasms (Liver Cancer)
08/2010 - 07/2002

Drug/Important Bio-Agent (IBA)

25Chimeric Antigen ReceptorsIBA
10/2022 - 01/2018
19Proteins (Proteins, Gene)FDA Link
03/2022 - 07/2002
14Messenger RNA (mRNA)IBA
01/2019 - 07/2002
10Inosine Triphosphate (ITP)IBA
03/2019 - 01/2011
8MicroRNAs (MicroRNA)IBA
01/2020 - 11/2010
7Estrogens (Estrogen)FDA Link
01/2014 - 01/2008
6Estrogen ReceptorsIBA
03/2022 - 06/2013
6CytokinesIBA
01/2021 - 01/2003
6Estrogen Receptor alphaIBA
01/2019 - 01/2008
6Biological ProductsIBA
01/2019 - 04/2010
6Complementary DNA (cDNA)IBA
10/2015 - 01/2002
5Long Noncoding RNAIBA
01/2022 - 01/2017
5Small Interfering RNA (siRNA)IBA
03/2021 - 06/2013
5Biomarkers (Surrogate Marker)IBA
07/2018 - 12/2012
4Pharmaceutical PreparationsIBA
05/2020 - 10/2003
4ErbB Receptors (EGF Receptor)IBA
01/2019 - 10/2006
4DNA (Deoxyribonucleic Acid)IBA
04/2014 - 02/2006
3B-Cell Maturation AntigenIBA
10/2022 - 10/2019
3bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
10/2022 - 10/2019
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 06/2010
3LigandsIBA
05/2020 - 01/2008
3SincalideFDA Link
05/2020 - 06/2013
3HGF activatorIBA
01/2019 - 10/2005
3Protein Isoforms (Isoforms)IBA
01/2019 - 01/2008
3TamoxifenFDA LinkGeneric
08/2017 - 02/2010
3Imatinib Mesylate (Gleevec)FDA Link
03/2016 - 06/2013
3Dexamethasone (Maxidex)FDA LinkGeneric
03/2015 - 06/2012
3Rituximab (Mabthera)FDA Link
03/2015 - 01/2011
3Interleukin-22 (IL-22)IBA
12/2012 - 10/2011
3human estrogen receptor alpha 36IBA
02/2010 - 01/2008
2Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2022 - 08/2019
2Single-Chain AntibodiesIBA
01/2022 - 01/2018
2Neoplasm Antigens (Tumor Antigens)IBA
01/2022 - 08/2010
2N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketoneIBA
05/2021 - 02/2017
2EnzymesIBA
01/2021 - 01/2021
2Hepatitis B Surface Antigens (HBsAg)FDA Link
10/2020 - 08/2018
2RNA (Ribonucleic Acid)IBA
02/2020 - 01/2017
2Cytokine Receptors (Cytokine Receptor)IBA
09/2019 - 09/2018
2TYK2 Kinase (Tyrosine Kinase 2)IBA
09/2019 - 09/2018
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2019 - 10/2017
2Glucose (Dextrose)FDA LinkGeneric
07/2018 - 01/2012
2Tyrosine Kinase InhibitorsIBA
10/2017 - 01/2014
2Proteinase-Activated ReceptorsIBA
05/2016 - 07/2011
2Hormones (Hormone)IBA
02/2016 - 06/2013
2Conditioned Culture MediaIBA
01/2016 - 09/2006
2DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
04/2015 - 03/2015
2Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA
03/2015 - 07/2002
2Fluorouracil (Carac)FDA LinkGeneric
01/2015 - 01/2003
2cadherin 5IBA
12/2014 - 06/2013
2GlucocorticoidsIBA
05/2013 - 01/2011
2AntigensIBA
06/2012 - 02/2006
2fluorescent protein 583IBA
10/2010 - 02/2010
2Angiogenesis InhibitorsIBA
09/2010 - 06/2010
2Peptides (Polypeptides)IBA
08/2010 - 02/2006
2Transcription Factors (Transcription Factor)IBA
04/2010 - 01/2008
2Doxorubicin (Adriamycin)FDA LinkGeneric
12/2009 - 10/2003

Therapy/Procedure

26Therapeutics
12/2022 - 02/2006
10Drug Therapy (Chemotherapy)
01/2021 - 01/2003
5Hematopoietic Stem Cell Transplantation
01/2021 - 12/2012
5Bone Marrow Transplantation (Transplantation, Bone Marrow)
12/2013 - 11/2007
4Catheter Ablation
01/2022 - 01/2011
4Radiofrequency Ablation
01/2022 - 08/2010
3Immunotherapy
01/2022 - 01/2020
3Transplantation
01/2021 - 01/2003
3Catheters
10/2014 - 11/2005
2Kyphoplasty
05/2022 - 01/2021